These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 29391330

  • 1. Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib.
    Christoforidou A, Kapsas G, Bezirgiannidou Z, Papamichos S, Kotsianidis Ι.
    Turk J Haematol; 2018 May 25; 35(2):147-149. PubMed ID: 29391330
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ibrutinib (PCI-32765) in chronic lymphocytic leukemia.
    Jain N, O'Brien S.
    Hematol Oncol Clin North Am; 2013 Aug 25; 27(4):851-60, x. PubMed ID: 23915749
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New approved indication for ibrutinib.
    Aschenbrenner DS.
    Am J Nurs; 2014 Jun 25; 114(6):21. PubMed ID: 24869579
    [No Abstract] [Full Text] [Related]

  • 15. The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia.
    Wiestner A.
    Haematologica; 2015 Dec 25; 100(12):1495-507. PubMed ID: 26628631
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The efficacy of ibrutinib in the treatment of Richter syndrome.
    Tsang M, Shanafelt TD, Call TG, Ding W, Chanan-Khan A, Leis JF, Nowakowski GS, Bowen D, Conte M, Schwager SM, Slager SL, Kay NE, Hanson CA, Parikh SA.
    Blood; 2015 Mar 05; 125(10):1676-8. PubMed ID: 25745187
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Central nervous system immune reconstitution inflammatory syndrome after ibrutinib therapy for Richter transformation.
    Chan KL, Lokan J, Tam CS, Lew TE, Prince HM.
    Leuk Lymphoma; 2017 Jan 05; 58(1):207-210. PubMed ID: 27326828
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.